• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical features and management of cystinuria.

作者信息

Dahlberg P J, Kurtz S B, Wilson D M, Smith L H

出版信息

Mayo Clin Proc. 1977 Sep;52(9):533-42.

PMID:895195
Abstract

Cystinuria is a complex hereditary disorder that affects both sexes with equal frequency and severity. Symptoms usually begin early (children and young adults) but may develop at any age. Stature is normal and there are no clinical nutritional abnormalities. The morbidity of cystine urolithiasis is considerable. Hyperuricemia is a frequent associated finding and is probably the result of multiple factors. No other abnormalities are consistently related to this disease. Treatment with adequate oral fluids to ensure a copious urine volume and with oral alkali to keep the urine alkaline is most successful when used prophylactically in the stone-free patient. However, dissolution of existing calculi is unlikely with this regimen alone. The addition of D-penicillamine often results in dissolution of stones and prevention of recurrent calculi in patients who have continued stone growth despite the use of oral fluids and alkali. Because toxic reactions with D-penicillamine are frequent and sometimes severe, this drug should be used only when necessary and then as an adjunct to rather than a substitute for increased oral fluids and alkali. Failure of treatment in spite of adequate therapy should alert the physician to the possibility of coexisting complicating problem.

摘要

相似文献

1
Clinical features and management of cystinuria.
Mayo Clin Proc. 1977 Sep;52(9):533-42.
2
Cystinuria.胱氨酸尿症
Endocrinol Metab Clin North Am. 1990 Dec;19(4):889-907.
3
[Clinical study on cystinuria in children--the stone management and the prevention of calculi recurrence].儿童胱氨酸尿症的临床研究——结石处理与预防结石复发
Nihon Hinyokika Gakkai Zasshi. 1998 Sep;89(9):758-65. doi: 10.5980/jpnjurol1989.89.758.
4
[Results of long-term treatment of cystine lithiasis with D-penicillamine].[D-青霉胺对胱氨酸结石的长期治疗结果]
Nephrologie. 1984;5(5):228-31.
5
New horizons in the management of patients with cystinuria.胱氨酸尿症患者管理的新领域。
Curr Opin Urol. 2010 Mar;20(2):169-73. doi: 10.1097/MOU.0b013e328333b674.
6
Management of the patient with cystinuria.胱氨酸尿症患者的管理
Urol Clin North Am. 1987 May;14(2):339-46.
7
Impact of a metabolic stone clinic on management of patients with cystinuria: 5 years follow-up.代谢性结石门诊对胱氨酸尿症患者管理的影响:5年随访
Clin Ter. 2010;161(4):341-4.
8
Characterization of patients with heterozygous cystinuria.胱氨酸尿症杂合子患者的特征。
Urology. 2012 Oct;80(4):795-9. doi: 10.1016/j.urology.2012.04.062. Epub 2012 Jul 31.
9
[Cystinuria and urolithiasis].[胱氨酸尿症与尿路结石]
Harefuah. 1995 Jul;129(1-2):12-5, 79.
10
[Cystine lithiasis: retrospective study about 25 cases].[胱氨酸结石:25例回顾性研究]
Tunis Med. 2008 Jun;86(6):556-9.

引用本文的文献

1
UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.更新 - 加拿大泌尿外科学会指南:肾结石的评估与药物治疗
Can Urol Assoc J. 2022 Jun;16(6):175-188. doi: 10.5489/cuaj.7872.
2
Crystalline structures of L-cysteine and L-cystine: a combined theoretical and experimental characterization.L-半胱氨酸和 L-胱氨酸的晶体结构:理论与实验综合表征。
Amino Acids. 2022 Aug;54(8):1123-1133. doi: 10.1007/s00726-022-03144-6. Epub 2022 Mar 16.
3
Update on cystine stones: current and future concepts in treatment.
胱氨酸结石的最新进展:治疗的现状与未来理念
Intractable Rare Dis Res. 2020 May;9(2):71-78. doi: 10.5582/irdr.2020.03006.
4
Urine proteomic profiling in patients with nephrolithiasis and cystinuria.尿蛋白质组谱分析在肾结石和胱氨酸尿症患者中的应用。
Int Urol Nephrol. 2019 Apr;51(4):593-599. doi: 10.1007/s11255-018-2044-1. Epub 2018 Dec 5.
5
Clinical Outcomes for Cystinuria Patients with Unilateral Versus Bilateral Cystine Stone Disease.单侧与双侧胱氨酸结石病的胱氨酸尿症患者的临床结局
J Endourol. 2018 Feb;32(2):148-153. doi: 10.1089/end.2017.0335. Epub 2018 Jan 3.
6
Delineation of cystinuria in Saudi Arabia: A case series.沙特阿拉伯胱氨酸尿症的描述:病例系列
BMC Nephrol. 2017 Feb 6;18(1):50. doi: 10.1186/s12882-017-0469-x.
7
CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.《加拿大泌尿外科协会肾结石患者评估与药物治疗指南——2016年更新版》
Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E347-E358. doi: 10.5489/cuaj.4218. Epub 2016 Nov 10.
8
How should patients with cystine stone disease be evaluated and treated in the twenty-first century?在21世纪,胱氨酸结石病患者应如何进行评估和治疗?
Urolithiasis. 2016 Feb;44(1):65-76. doi: 10.1007/s00240-015-0841-x. Epub 2015 Nov 27.
9
Urine proteomic analysis in cystinuric children with renal stones.胱氨酸尿症合并肾结石患儿的尿液蛋白质组学分析
J Pediatr Urol. 2015 Aug;11(4):217.e1-6. doi: 10.1016/j.jpurol.2015.04.020. Epub 2015 May 29.
10
CKD and Its Risk Factors among Patients with Cystinuria.胱氨酸尿症患者中的慢性肾脏病及其危险因素
Clin J Am Soc Nephrol. 2015 May 7;10(5):842-51. doi: 10.2215/CJN.06680714. Epub 2015 Feb 25.